drugset / Trial / NCT02587988

Trial to Evaluate the Efficacy and Safety of HCP1302

NCT02587988

Phase 3 Completed 232 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

Trial to Evaluate the Efficacy and Safety of HCP1302

Timeline

Start
2014-09
Primary completion
2015-05
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified
Subject HCP1302 Unknown